NCBI PubMed NLMPubMed
Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
  Limits Preview/Index History Clipboard Details    
spacer gif About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby

Related Resources
Order Documents
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central


 Show: 

1: Int J Neuropsychopharmacol. 2004 Sep;:1-6. [Epub ahead of print] Related Articles, Links

A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate.

Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF.

Department of Psychological Medicine, Womens and Childrens Health Service Subiaco, WA, Australia.

Antidepressants are often used antenatally, and placental transfer may lead to adverse effects (toxicity) in the neonate. Pregnant women taking fluoxetine (n=4), sertraline (n=4), paroxetine (n=2) or venlafaxine (n=1) in the last trimester were studied. Maternal and cord sera were collected at delivery and infant serum on day 5 after birth for measurement of antidepressant concentrations. Neonatal Abstinence Scores (NAS) were measured in the infants on days 13 after birth. In maternal serum, median drug concentrations were: fluoxetine (96 gl), norfluoxetine (110 gl), sertraline (11 gl), desmethylsertraline (38 gl), paroxetine (mean 12 gl), venlafaxine (220 gl), and O-desmethylvenlafaxine (392 gl). Corresponding median values in cord serum were: fluoxetine (65 gl), norfluoxetine (81 gl), sertraline (10 gl), desmethylsertraline (27 gl), paroxetine (mean 6 gl), venlafaxine (232 gl), and O-desmethylvenlafaxine (406 gl). Corresponding median cordmaternal concentration ratios were 0.67 for fluoxetine and 0.72 for norfluoxetine, 0.67 for sertraline and 0.63 for demethylsertraline, 0.52 (mean) for paroxetine, and 1.1 and 1.0 for venlafaxine and O-desmethylvenlafaxine respectively. The neonates of two patients taking fluoxetine had high NAS. Only fluoxetine and norfluoxetine were detected in infant serum. Our data show substantial placental transfer of antidepressants, but only fluoxetine persisted in the infants serum. Neonatal toxicity may be associated with serotonin uptake blockade, and also be influenced by neonatal clearance.

PMID: 15035694 [PubMed - as supplied by publisher]


 Show: